Fennec Pharmaceuticals (FRX.TO) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.3
-0.21
-0.13
-0.05

Details

Expected EPS
-0.04814414582705
Actual EPS
-0.15391050230985
Surprise EPS
-0.11
Surprise Percent
+219.69%

Description

Fennec Pharmaceuticals (FRX.TO) has reported earnings of -0.15391050230985 per share for Q3 2025.

0 Comments

Share your thoughts